Object Details
- Genentech Inc.
- Description (Brief)
- Protropin is an injectable, recombinant pharmaceutical that is used to treat children with growth problems stemming from an inability to produce their own growth hormone.
- Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human growth hormone are inserted into bacteria. Bacteria produce the growth hormone, which is harvested and used as the active ingredient in Protropin.
- Object consists of a sealed cardboard box with light blue, dark blue, and black printing. Box contains two vials Protropin and one vial Bacteriostatic Water for injection.
- Location
- Currently not on view
- ca 1987
- ID Number
- 1987.0789.02
- accession number
- 1987.0789
- catalog number
- 1987.0789.02
- Object Name
- pharmaceutical
- biological
- Physical Description
- somatrem, 5 mg or 10 IU (drug active ingredients)
- mannitol, 40.0 mg (drug active ingredients)
- sodium phosphate, 1.7 mg (drug active ingredients)
- Measurements
- overall: 13.3 cm x 11 cm x 5 cm; 5 1/4 in x 4 5/16 in x 1 15/16 in
- place made
- United States: California, San Francisco
- See more items in
- Medicine and Science: Medicine
- Health & Medicine
- Biotechnology and Genetics
- Recombinant Pharmaceuticals
- Science & Mathematics
- National Museum of American History
- Record ID
- nmah_1409332
- GUID (Link to Original Record)
- https://n2t.net/ark:/65665/ng49ca746ad-5c66-704b-e053-15f76fa0b4fa
